Research-driven, innovation-led
life sciences company
OUR STORY
Zanoprima has deep roots in pharmaceutical research and nicotine innovation. Ashok Narasimhan, one of our founders, hails from India, which has the highest number of cases of oral cancer in the world. He was very concerned about this problem and was determined to find a solution for it. Ashok began developing nicotine replacement therapy (NRT) products in 1997
In 2002, he successfully launched India’s first NRT chewing gum, marketed through medical channels, affordably priced in local flavours for wide appeal. He also developed and gained approval for a nicotine lozenge. After selling his NRT franchise, he and Nicholas Hyde founded Zanoprima. Drawing on their combined pharmaceutical industry experience, they set the ambitious goal of developing a cost-effective synthesis of pharmaceutical-quality (S)-nicotine. Passion drove them from concept to lab, and lab to product.
OUR PURPOSE
At Zanoprima, we are passionate about using scientific research and innovation to:
Enable and advance the transition towards a cigarette free world, thereby eliminating the particle most linked to poor health and death worldwide.
Create superior and sustainable alternatives to the cigarette.
Harness the potential of synthetic nicotine and medicinal plants to treat major human ailments.
We innovate to create a healthier planet.
OUR INNOVATION
Introducing high purity (typically 99.9%), synthetic (S)-Nicotine (SyNic) for commercial use that is free of related tobacco alkaloids, TSNAs (tobacco-specific nitrosamines), odour and harsh taste.
SyNic is not obtained from any part of tobacco and not derived from a synthetic racemic mixture.
OUR IMPACT
Our innovative products and processes at Zanoprima are centered around creating a positive impact on our planet. Our objective is to reduce and ultimately eliminate the harmful effects of smoking and unclean nicotine products on our environment, our society and health.
Our Green Chemistry process is sustainable and eco-friendly.
HOW OUR CUSTOMERS BENEFIT
Zanoprima-developed products deliver many advantages:
A regular and fully traceable supply of (S)-nicotine, with consistent batch-to-batch quality.
None of the impurities or contaminants (TSNAs, heavy metals, pesticides), or related tobacco alkaloids, potentially found in plant-derived nicotine.
Predictable costs that are comparable to pharmaceutical-grade plant-derived nicotine.
Minimal waste, low energy consumption, and minimal environmental impact.
With clean chemistry, Zanoprima solves problems of nicotine’s past, while looking towards future needs and goals, including sustainable production.
Our Green Chemistry process is sustainable and eco-friendly.
OUR PURPOSE
We are passionate about using scientific research and innovation to:
Enable the transition towards tobacco-free world, thereby addressing the single most preventable cause of health and death worldwide
Create sustainable and environment friendly alternatives to tobacco products
Harness the potential of synthetic nicotine and medicinal plants to treat major human ailments
We innovate to create a healthier planet.
OUR INNOVATION
Introducing high purity (typically 99.9%), synthetic (S)-Nicotine (SyNic) for commercial use that is free of TSNA (tobacco specific Nitrosamines), toxins, carcinogens, odour, and harsh taste.
OUR IMPACT
Our innovative products and processes are centered around creating a positive impact on our planet. Our objective is to reduce and ultimately eliminate the harmful effects of tobacco on our environment, our society and health.
Our Green Chemistry process is sustainable and eco-friendly.
